Peak6 Investments LLC Esperion Therapeutics, Inc. Transaction History

Peak6 Investments LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 14, 2020	SELL	$27.44 - $73.84 $32,296 - $86,909	-1,177 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$35.4 - $59.82 $446,606 - $754,689	-12,616 Reduced 91.47%	1,177 $70,000
Q3 2019 Nov 08, 2019	SELL	$34.47 - $47.53 $222,676 - $307,043	-6,460 Reduced 31.9%	13,793 $506,000
Q2 2019 Aug 14, 2019	SELL	$40.1 - $52.33 $47,598 - $62,115	-1,187 Reduced 5.54%	20,253 $942,000
Q1 2019 May 15, 2019	BUY	$40.11 - $53.57 $859,958 - $1.15 Million	21,440 New	21,440 $861,000

207

128M

1.67M

930K

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $155M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Peak6 Investments LLC with notifications on news.